Dec 20, 2011
Posted by Web Designer and Website Topics on Dec 20, 2011 in Construction | 0 comments
(PRWEB) December 19, 2011
The Mesothelioma Victims Center says, “Mesothelioma is an incredibly rare form of cancer related to exposure to asbestos. This year between 2000, and 3000 US citizens will be diagnosed with mesothelioma. Of this group of mesothelioma victims, about one third will be Veterans of the United States Navy.” The group says, “When it comes to a mesothelioma diagnosis we are game changers for the individual, or US Navy veteran dealing with this very rare form of can cancer, and we like to think we are game changers for the families of the victim, because we offer honest, and extremely helpful free services no one else does. We also offer something else, an individual, or family dealing with a mesothelioma diagnosis will not find in a cable TV ad offering help for a mesothelioma victim, or a disingenuous web site offering mesothelioma help on the Internet. We offer integrity, and the best possible resources for victims of mesothelioma, and no other group, or organization does this.” http://MesotheliomaVictimsCenter.Com
The Mesothelioma Victim Center’s Bill of Rights includes:
The names and specific contacts for the most successful, and reputable mesothelioma attorneys, or mesothelioma trial lawyers in the United States.
A customized mesothelioma cancer treatment options report, that is designed to identify the best mesothelioma cancer treatment options, in the specific area, region, and nation for a victim of mesothelioma.
The Mesothelioma Victims Center will always be on call to any family dealing with mesothelioma. This includes assisting a family with how to live with mesothelioma, assistance with hospice, or any other need they may have.
Who can get Mesothelioma? Mesothelioma is linked to exposure to asbestos. Individuals who served in the US Navy, or as oil refinery workers, ship yard workers, employees of defense contractors, rail road workers, power plant workers, chemical industry workers, automotive repair specialists, construction workers, plumbers, demolition contractors, were all exposed to asbestos in the 1940′s, 1950′s, 1960′s, 1070′s, and 1980′s. Tragically, one third of all US mesothelioma victims served in the United States Navy, or are US Navy Veterans. The Mesothelioma Victims Center says, “The worst thing about a mesothelioma cancer diagnosis is typically it comes out of the blue. Frequently, an individual served in the US Navy, worked in a power plant, an oil refinery, or a shipyard decades ago, they get pneumonia type symptoms, it does not get better, and in some cases the doctors finally figure out its mesothelioma.” Individuals, or families dealing with a mesothelioma diagnosis, or living with mesothelioma are encouraged to contact the Mesothelioma Victims Center anytime at 866-714-6466 for their unparalleled free services. http://MesotheliomaVictimsCenter.Com.
###
Dec 14, 2011
Posted by Web Designer and Website Topics on Dec 14, 2011 in Construction | 0 comments
Baltimore, MD (PRWEB) December 14, 2011
December 8th, 2011: SNBL-CPC one of the nations leading CRO dedicated to Phase I & IIa clinical research is pleased to announce new executive leadership with the arrival of Patrick R. Ayd as Chief Operating Officer (COO). As COO, Mr. Ayd will have overall responsibility managing SNBL-CPCs clinical, administrative, and business development departments and optimizing the SNBL-CPC research platform to perform enhanced Phase I/IIa clinical trials of the highest quality for a wide variety of industry sponsors who require the utmost level of quality and white glove service when executing their Early Phase clinical trials.
Mr. Ayd was the former Vice President of Operations at SNBL-CPC. He managed the design and construction of the state of the art 96 bed Phase I facility which is located in the BioPark on the campus of the University of Maryland in Baltimore, MD. Mr. Ayd joins us from ClinPharm Network, Inc. where he served as the principal and founder of this small Early Phase operations and quality assurance consulting firm. He has held similar management & leadership positions in the clinical research industry including Omnicare Clinical Research, Biokenetic Clinical Applications, Bioanalytical Systems, Inc., and Parexels Clinical Research Unit in Baltimore. Mr. Ayd has over two decades of health care management experience, & his deep knowledge and experience in sourcing early phase clinical trials and managing Clinical Pharmacology Units will be of significant value to SNBL-CPC and all its customers who are seeking a strategic partner.
Takeshi KC Yamakawa CEO of SNBL-CPC stated, It is fantastic to have Patrick back at SNBL. Patrick was a critical partner in establishing the SNBL unit in Baltimore. The infrastructure and operational foundation that he established 6 years ago assisted us in developing into a state of the art first in class inpatient clinical research facility. SNBL-CPC has always been a leader in the clinical research industry. Our growth is accelerating and it is critical to have a leader who can leverage our growth to build out our presence in the Early Phase inpatient clinical pharmacology arena and guide SNBL-CPC through multiple testing sectors such as adaptive design trials, special patient populations, infectious disease challenge trials, etc. The tradition of utilizing our capabilities to assist our clients clinical development program will continue. Patrick was the obvious choice to manage our growth and continue the highest level of quality work that SNBL-CPC is known for in the Early Phase research industry.
About SNBL Clinical Pharmacology Center:
SNBL-CPC is a 96 bed full service Clinical Pharmacology Research facility based in Baltimore, Maryland. Our team is focused on performing high complexity early phase clinical research programs. We conduct clinical trials for multiple segments of clients, including, pharmaceutical, biotech, academic, and government. In addition, SNBL-CPC offers all ancillary trial support services such as protocol consulting and design, data management, etc. for early phase I-IIa studies. SNBLs focus is on First In-Human, Dose Escalation, SAD, MAD, Food Effect, Novel Delivery, Adaptive design, and Infectious Disease challenge studies sets us apart from the vast majority of Early Phase inpatient clinical research facilities. SNBL-CPC is pleased to offer our new, state of the art clinical safety laboratory that performs all of the standard safety analyses and moderate to high complexity test procedures.
For further information about SNBL-CPC or having our team mange your early phase clinical development program, please contact our client service team at bd(at)snbl-cpc(dot)com or visit our website at http://www.snbl-cpc.com.
SNBL-CPC
Felipe Troncoso
+1 (410) 706 8894
ftroncoso(at)snbl-cpc(dot)com
###
